:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/910mediagroup/AZT6QUA7ZBIRNKYWCTZKXYSA7M.jpg)
HER2-positive cancers are aggressive, but the good news is many can be treated with targeted therapies.
The bad news, those drugs can hurt the heart.
Now, researchers have found a way to successfully treat HER2-positive cancer and protect patients from heart failure.
Courtney Hunter shows you how in Healthy Living.
Nanci remains cancer-free but will have to stay on targeted therapies for the rest of her life.
Dr. Barac says all of the women in the SAFE-HEaRt trial, with the exception of three, were able to remain on their cancer therapies safely during the trial.
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/910mediagroup/FMNHMARFHBN7XM3IUITD5FEE7I.jpg)
© 2023 - 910 Media Group